FindTrial
Sign In

Treatment of chronic sinusitis by nuskha joshanda nazla barid.

Therapeutic evaluation of the unani formulation in management of warm tajaweef-e- anaf muzmin -A randomised open study with placebo - CS-NJNB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051156
Enrollment
60
Registered
2023-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: decoction of joshanda nazla barid: The contents of one polypacks containing 31 grams of crushed drugs will be soaked in 200 ml of water for an entire night. Next morning, soaked drugs a

Sponsors

Department of moalejat Ajmal khan tibbiya college Aligarh Muslim university Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients of chronic sinusitis through objective parameters[Assessment of opacity and Assessment of mucosal thickening by xray pns w/v] and subjective parameters[1. Nasal Obstruction 2. Nasal discharge 3. Sneezing 4. Headache 5.Post nasal drip 6.Abnormalites of smell 7.Heaviness in head 8. Tenderness of sinuses] Patients of both sexes. Patients in the age group of 20 to 60 years. Those who give written consent.

Exclusion criteria

Exclusion criteria: Patients below 20 years of age. Patients above 60 years of age. Pregnant & lactating mothers. Patients who fail to give consent. Patients who fail to follow up. Mentally retarded persons. • Patients of diabetes mellitus or any comorbid disease. • Malignancy of nose and paranasal sinuses. • Patients having any history of trauma to nose or sinus area, any surgery of nose or paranasal sinuses. • Patients having any congenital and acquired structural abnormality of the nasal cavity. • Any medical condition where physician feels that participation in the study could be detrimental to patient well being.

Design outcomes

Primary

MeasureTime frame
improvement in Objective parameters Assessment of opacity Assessment of mucosal thickening through arbitary gradingTimepoint: 45 days with basline and after completion.—

Secondary

MeasureTime frame
improvement in Subjective parameters 1. Nasal Obstruction 2. Nasal discharge 3. Sneezing 4. Headache 5.Post nasal drip 6.Abnormalites of smell 7.Heaviness in head 8. Tenderness of sinuses through arbitary grading.Timepoint: 45 days on fortnighly follow ups.—

Countries

India

Contacts

Public ContactShamaila khan

ajmal khan tibbiya college faculty of unani medicine moalejat

tanzeel1967@gmail.com9448123337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026